Stay updated on Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.

Latest updates to the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page's version label was updated from Revision: v3.6.4 to v3.6.5, indicating a new deployment. This update is a metadata change reflecting deployment activity rather than a change to the study information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPublications section was added, featuring the BilT-02 Clin Cancer Res. citation and a 'From PubMed' note indicating automated PubMed population. The revision tag on the page updated from v3.6.3 to v3.6.4.SummaryDifference0.3%

- Check49 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a minor version update to the page rendering.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now shows revision v3.6.2, replacing the previous v3.6.0, indicating a newer revision in the page's history.SummaryDifference0.1%

- Check70 days agoChange DetectedEnrollment status now includes a 'No longer looking for participants' notice, signaling that the study is not accepting new participants. In addition, new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added to assist users in understanding and engaging with the study details.SummaryDifference0.4%

- Check77 days agoChange DetectedThe page's revision tag changed from v3.5.4 to v3.5.5, signaling a minor update to the study record.SummaryDifference0.1%

Stay in the know with updates to Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.